
    
      Predictive role of a point-of-care assay (VerifyNow test) has not been well evaluated in
      large number of patients receiving drug-eluting stents as a routine practice.

      In addition, additional predictive effect of a point-of-care assay, as compared to
      conventional clinical factors or other biomarkers, might be clinically interesting and
      important.
    
  